Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Independent evaluation finds GAVI funding to poor countries can boost childhood vaccine coverage

19.09.2006
But countries with initial coverage greater than 65% showed no effect

The Global Alliance for Vaccines and Immunization (GAVI) was created in 1999 with the goal of enabling even the poorest countries to provide vaccines to all children. A study by researchers associated with the Harvard Initiative for Global Health set out to measure the extent to which GAVI funding had succeeded in raising the percentage of children who received the combined diphtheria, tetanus and pertussis vaccine (DTP3) and whether the cost had been close to GAVI's original estimates of $20 per additional child immunized.

Their analysis appears in advance online in the September 21, 2006 issue of the Lancet, www.thelancet.com.

GAVI is a public-private global health partnership that was created when vaccine coverage in many countries was dropping. Countries with a gross national income of less than US$1000 per capita per year and with coverage under 80% were eligible to receive financial support from GAVI to develop immunization services, including personnel, infrastructure and supplies, as part of their national health system. Decisions on how resources are spent are left to the individual countries, but continued authorization of funding is tied to meeting yearly immunization coverage targets set by the countries.

Research Associate Chunling Lu and colleagues from the Harvard School of Public Health (HSPH) analyzed the relationship between DTP3 coverage for GAVI recipient countries from 1995 to 2004 and immunization services spending (ISS) per surviving child in 53 countries. The analysis revealed that in countries with DTP3 coverage of 65% or less at the start of the program, ISS spending had a significant positive effect on DTP3 coverage, raising coverage from under 50% in many countries to close to 65%.

However, in countries with initial DTP3 coverage of more than 65%, GAVI spending did not translate into increased immunization coverage.

The estimated cost per additional child immunized was less than $14. But if non-ISS expenditures are included, such as for new and underused vaccine and safe injection equipment, the cost per child approaches $20, close to GAVI's original estimates.

Between 2000 and 2005, total GAVI disbursements were $760.5 million, of which $124-125 million (16%) were for immunization services spending.

Based on their analysis, the researchers recommend that GAVI consider redistributing its resources to countries with the lowest immunization coverage.

"Assessment of the effect of GAVI is important not only because of the alliance's mission and the resources devoted to this effort," write the researchers, "but also because the project represents an important innovation in global health. Together with Stop TB and Roll Back Malaria, GAVI was one of the first major global health initiatives designed to create new public-private partnerships to tackle major health problems."

Unlike these other global health initiatives, however, for which there is no reliable indicator of effect on health, GAVI afforded an opportunity for concrete measure of public health improvement.

"This is the first time that there is hard evidence that one of the major global health programs is having a real impact; the world desperately needs similar analyses for AIDS, tuberculosis, malaria and other initiatives," said senior author Christopher J. Murray, Richard Saltonstall Professor of Population Policy at HSPH and director of the Harvard Initiative for Global Health.

Said Lu: "Our research shows conclusively that GAVI, as an experiment to provide financial help to countries with poor performance in DTP3 coverage, is effective in bringing vaccine protection to the world's most disadvantaged children."

Todd Datz | EurekAlert!
Further information:
http://www.hsph.harvard.edu

More articles from Studies and Analyses:

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>